Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Slides:



Advertisements
Similar presentations
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.
Advertisements

Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized.
Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J
Volume 146, Issue 5, Pages (November 2014)
Volume 81, Issue 5, Pages (March 2012)
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.
Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation  Lena Rivard, MD, MSc, Paul Khairy, MD,
A contemporary analysis of pulmonary hypertension in patients undergoing mitral valve surgery: Is this a risk factor?  Daniel H. Enter, MD, Anthony Zaki,
Chapter 6: CKD among Children and Adolescents
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease  Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,
Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD 
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias  Jorge E. Cortes, Carlo Gambacorti-Passerini,
Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients  Jiacong Luo, MD, MS, MPH, Donna E.
Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data  Kathleen Lang,
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Dysfunctional Uterine Activity in Labour and Premature Adverse Cardiac Events: Population-Based Cohort Study  Alyssa Kahane, BSc, Alison L. Park, MSc,
Cardiovascular Disease and CKD: Core Curriculum 2010
Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery  Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,
John P. Middleton, Patrick H. Pun  Kidney International 
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study  C.A. Rushton, U.T. Kadam  International.
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world.
Type of vascular access and mortality in U.S. hemodialysis patients
Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic.
Syncope: Outcomes and Conditions Associated with Hospitalization
Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France  Nicolas Despiégel, Chantal Touboul, Alain.
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study  Vasilios Papademetriou, MD, DSc, Eric.
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W.
Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and.
Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis  Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,
Guidelines for the Older Adult With CKD
Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
Management of Heart Failure in Advancing CKD: Core Curriculum 2018
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera.
CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.
Volume 77, Issue 7, Pages (April 2010)
Volume 77, Issue 2, Pages (January 2010)
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data  Preetesh Jain, Hagop Kantarjian,
Volume 81, Issue 5, Pages (March 2012)
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.
Volume 73, Issue 12, Pages (June 2008)
Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice  Abdalla Awidi, Salah Abbasi,
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review  Jill A. Bell, Aaron.
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen.
Cardiovascular risk factors in chronic kidney disease
International Journal of Cardiology
Volume 73, Issue 8, Pages (April 2008)
Volume 145, Issue 5, Pages e3 (November 2013)
Volume 68, Issue 1, Pages (July 2005)
Cardiovascular risk in chronic kidney disease
Volume 75, Issue 1, Pages (January 2009)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system  Victoria A. Kumar, Margo A. Sidell,
Volume 16, Issue 6, Pages (June 2019)
Presentation transcript:

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study  Kristin D. Kistler, Jill Kalman, Gagan Sahni, Brian Murphy, Winifred Werther, Kanya Rajangam, Ajai Chari  Clinical Lymphoma, Myeloma and Leukemia  Volume 17, Issue 2, Pages 89-96.e3 (February 2017) DOI: 10.1016/j.clml.2016.11.009 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Prevalence of Cardiac Events Among Patients With and Without Multiple Myeloma Abbreviations: CHF = congestive heart failure; IHD = ischemic heart disease. Clinical Lymphoma, Myeloma and Leukemia 2017 17, 89-96.e3DOI: (10.1016/j.clml.2016.11.009) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Adjusted Hazard Ratios (HRs) for Cardiac Events Among Patients With Multiple Myeloma (MM) Versus Patients Without MM. Factors Modifying the HR for MM by ≥ 10% Were Included in the Analyses. Each Analysis Was Limited to Patients Without the Outcome Event During Baseline. Ischemic Heart Disease (IHD) Was Adjusted for Any Other Baseline Cardiac Comorbidity, Cardiac Dysrhythmias, Charlson Comorbidity Index (CCI) Score, and Chronic Kidney Disease (CKD). Congestive Heart Failure (CHF) Was Adjusted for Baseline Anthracycline Exposure, Any Other Baseline Cardiac Comorbidity, Cardiac Dysrhythmias, CCI Score, and CKD. Cardiomyopathy and Conduction Disorders Were Adjusted for Any Other Baseline Cardiac Comorbidity, Cardiac Dysrhythmias, CHF, CCI Score, and CKD. Cardiac Dysrhythmia Events Were Adjusted for CCI Score. Hypertensive or Arterial Events Were Adjusted for Any Other Baseline Cardiac Comorbidity. HRs Adjusted for Covariates that Modified the HR for MM by ≥ 10% and Included the Following Variables for Each Outcome: Any Cardiac Event: No Covariates Identified; Hypertensive or Arterial Events: Any Cardiovascular Event During Baseline; Cardiac Dysrhythmias: CCI; Conduction Disorders: Any Cardiovascular Event During Baseline, Cardiac Dysrhythmias During Baseline, CHF During Baseline, CCI, CKD; Cardiomyopathy: Any Cardiovascular Event During Baseline, Cardiac Dysrhythmias During Baseline, CHF During Baseline, CCI, CKD; CHF: Any Cardiovascular Event During Baseline, Cardiac Dysrhythmias During Baseline, Anthracycline Exposure, CCI, CKD; IHD: Any CV Event During Baseline, Cardiac Dysrhythmias During Baseline, CCI, CKD Clinical Lymphoma, Myeloma and Leukemia 2017 17, 89-96.e3DOI: (10.1016/j.clml.2016.11.009) Copyright © 2016 The Authors Terms and Conditions

Supplemental Figure 1 Incidence Rates and Incidence Rate Ratios of Cardiac Events Among Patients With and Without Multiple Myeloma. (A) Incidence Rates and 95% Confidence Intervals. (B) Incidence Rate Ratios and 95% Confidence Intervals Abbreviations: CHF = congestive heart failure; IHD = ischemic heart disease. Clinical Lymphoma, Myeloma and Leukemia 2017 17, 89-96.e3DOI: (10.1016/j.clml.2016.11.009) Copyright © 2016 The Authors Terms and Conditions